Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Autologous Bone Marrow Mononuclear Cell Implantation and Its Impact on the Outcome of Patients With Critical Limb Ischemia　- Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
Pignon B, Sevestre MA, Kanagaratnam L, Pernod G, Stephan D, Emmerich J, Clement C, Sarlon G, Boulon C, Tournois C, Nguyen P. Pignon B, et al. Circ J. 2017 Oct 25;81(11):1713-1720. doi: 10.1253/circj.CJ-17-0045. Epub 2017 Jun 10. Circ J. 2017. PMID: 28603176 Free article. Clinical Trial.
[Fibrinogen: a risk factor].
Potron G, N'Guyen P, Pignon B. Potron G, et al. Among authors: pignon b. J Mal Vasc. 1996;21(3):126-32. J Mal Vasc. 1996. PMID: 8965039 Review. French.
Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
Ifrah N, Witz F, Jouet JP, François S, Lamy T, Linassier C, Pignon B, Berthou C, Guyotat D, Cahn JY, Harousseau JL. Ifrah N, et al. Among authors: pignon b. Cancer. 1999 Oct 15;86(8):1496-505. doi: 10.1002/(sici)1097-0142(19991015)86:8<1496::aid-cncr16>3.0.co;2-#. Cancer. 1999. PMID: 10526278 Clinical Trial.
A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
Witz F, Sadoun A, Perrin MC, Berthou C, Brière J, Cahn JY, Lioure B, Witz B, François S, Desablens B, Pignon B, Le Prisé PY, Audhuy B, Caillot D, Casassus P, Delain M, Christian B, Tellier Z, Polin V, Hurteloup P, Harousseau JL. Witz F, et al. Among authors: pignon b. Blood. 1998 Apr 15;91(8):2722-30. Blood. 1998. PMID: 9531581 Free article. Clinical Trial.
157 results